Doddie’s Grand Tour - the 2025 edition of Rob Wainwright’s ride to raise vital funds for MND research - saw 30 teams complete a four-day cycle from Dublin to Edinburgh, raising over £1 million for My Name’5 Doddie Foundation in the process. 

So, what’s in store for 2026? Rob and his team have just announced they will be back next year with another epic ride - Doddie’s Triple Crown.

Doddie’s Triple Crown is an 800-mile cycle from Melrose to Dublin, taking place from 10-13 March next year. The aim? To raise further, and much needed, funds for MND research. 

Teams of cyclists will cover 800 miles on their bikes over the four days of the challenge, and will arrive in Dublin the evening before the Ireland vs Scotland Six Nations Championship match at the Aviva Stadium. A super start to Super Saturday! 

The route for Doddie’s Triple Crown is as follows, and will see cyclists pass through all four UK nations:

  • Day 1 (10 March): Melrose to Leeds
  • Day 2 (11 March): Leeds to Gloucester
  • Day 3 (12 March): Gloucester to Fishguard - with an overnight ferry to Ireland
  • Day 4 (13 March): Pembroke Dock to Dublin

More news & stories

View all
 picture
Fundraising MND stories
13 Oct 2026

Kathy dedicates Women of the Year honour to the MND community

Kathy Weir's dedication to people affected by motor neuron disease (MND) has been recognised with the Campaigning Champions Award at the 72nd Women of the Year Lunch…
Read more
 picture
Research
13 Oct 2026

Multimillion-pound partnership breaks down barriers in MND research

Motor neuron disease (MND) is one of the most complex challenges in medical research. While excellent work is taking place across the globe, no single researcher…
Read more
 picture
Research
12 Oct 2026

EXPERTS-ALS rules out Ropinirole as a potential treatment for MND

The latest results from the EXPERTS-ALS clinical trial have shown that Ropinirole is unlikely to be an effective treatment for motor neuron disease (MND), and the…
Read more
Bell icon

Join our Newsletter!

By subscribing, you confirm that you agree with our terms and conditions.